FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
2.950
+0.200 (7.27%)
At close: Oct 30, 2024, 4:00 PM
3.100
+0.150 (5.08%)
After-hours: Oct 30, 2024, 6:32 PM EDT
FibroBiologics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for FibroBiologics stock have an average target of 13.33, with a low estimate of 12 and a high estimate of 16. The average target predicts an increase of 351.86% from the current stock price of 2.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for FibroBiologics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Sep '24 | Oct '24 |
---|---|---|
Strong Buy | 2 | 3 |
Buy | 0 | 0 |
Hold | 0 | 0 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 2 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +306.78% | Oct 30, 2024 |
EF Hutton | EF Hutton | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +442.37% | Oct 18, 2024 |
Maxim Group | Maxim Group | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +306.78% | Sep 24, 2024 |
EF Hutton | EF Hutton | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +442.37% | Sep 13, 2024 |
EF Hutton | EF Hutton | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +442.37% | Sep 4, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.41
from -0.68
EPS Next Year
-0.29
from -0.41
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -0.39 | -0.28 | -0.30 |
Avg | -0.41 | -0.29 | -0.35 |
Low | -0.42 | -0.28 | -0.38 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.